Circulating tumor DNA profile recognizes transformation to castration-resistant neuroendocrine prostate cancerHimisha Beltran, Francesca Demichelis, Alessandro Romanel et al.|Journal of Clinical Investigation|2020Cited by 194
Subclone-specific microenvironmental impact and drug response in refractory multiple myeloma revealed by single‐cell transcriptomicsStephan M. Tirier, Karsten Rippe, Jan‐Philipp Mallm et al.|Nature Communications|2021Cited by 141
Whole exome sequencing (WES) of circulating tumor DNA (ctDNA) in patients with neuroendocrine prostate cancer (NEPC) informs tumor heterogeneity.Himisha Beltran, Francesca Demichelis, Alessandro Romanel et al.|Journal of Clinical Oncology|2017Cited by 15
ABEMUS: platform-specific and data-informed detection of somatic SNVs in cfDNANicola Casiraghi, Alessandro Romanel, Francesco Orlando et al.|Bioinformatics|2020Cited by 13
Circulating tumor DNA (ctDNA) to detect neuroendocrine prostate cancer genomic and DNA methylation changes.Himisha Beltran, Francesca Demichelis, Alessandro Romanel et al.|Journal of Clinical Oncology|2020Cited by 2